Ritter Daniher Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Ritter Daniher Financial Advisory's VRTX Position: Q2 2026 in Review
Ritter Daniher Financial Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 9.6% in Q2 2026, selling an estimated $12K and leaving 255 shares worth $127K. The position accounts for 0.02% of the portfolio, ranked #203.
Ritter Daniher Financial Advisory first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $164K in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ritter Daniher Financial Advisory held 255 shares of Vertex Pharmaceuticals worth $127K as of Q2 2026.
- Ritter Daniher Financial Advisory sold 27 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12K.
- Vertex Pharmaceuticals made up 0.02% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #203 holding.
- Ritter Daniher Financial Advisory first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- Ritter Daniher Financial Advisory's Vertex Pharmaceuticals position peaked at $164K in Q4 2023.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.